PL2700411T3 - Probiotyki, wydzielnicze IgA a zakażenie - Google Patents

Probiotyki, wydzielnicze IgA a zakażenie

Info

Publication number
PL2700411T3
PL2700411T3 PL13188128T PL13188128T PL2700411T3 PL 2700411 T3 PL2700411 T3 PL 2700411T3 PL 13188128 T PL13188128 T PL 13188128T PL 13188128 T PL13188128 T PL 13188128T PL 2700411 T3 PL2700411 T3 PL 2700411T3
Authority
PL
Poland
Prior art keywords
probiotics
infection
secretory iga
secretory
iga
Prior art date
Application number
PL13188128T
Other languages
English (en)
Inventor
Jalil Benyacoub
Blaise Corthesy
Stéphanie Blum-Sperisen
Laurent Favre
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39832407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2700411(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL2700411T3 publication Critical patent/PL2700411T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL13188128T 2008-06-24 2009-06-16 Probiotyki, wydzielnicze IgA a zakażenie PL2700411T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08158833A EP2138187A1 (en) 2008-06-24 2008-06-24 Probiotics, secretory IgA and infection
EP13188128.6A EP2700411B1 (en) 2008-06-24 2009-06-16 Probiotics, secretory IgA and infection

Publications (1)

Publication Number Publication Date
PL2700411T3 true PL2700411T3 (pl) 2017-06-30

Family

ID=39832407

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09769156T PL2318047T3 (pl) 2008-06-24 2009-06-16 Probiotyki, wydzielnicze iga a zakażenie
PL13188128T PL2700411T3 (pl) 2008-06-24 2009-06-16 Probiotyki, wydzielnicze IgA a zakażenie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09769156T PL2318047T3 (pl) 2008-06-24 2009-06-16 Probiotyki, wydzielnicze iga a zakażenie

Country Status (11)

Country Link
US (3) US9173937B2 (pl)
EP (3) EP2138187A1 (pl)
JP (1) JP2011525484A (pl)
CN (2) CN102076361A (pl)
AU (1) AU2009264423B2 (pl)
BR (1) BRPI0914624B1 (pl)
CA (1) CA2727303A1 (pl)
ES (2) ES2616334T3 (pl)
PL (2) PL2318047T3 (pl)
PT (2) PT2700411T (pl)
WO (1) WO2009156307A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2138186A1 (en) * 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
JP2012180304A (ja) * 2011-03-01 2012-09-20 Biseibutsu Kagaku Kenkyusho:Kk 鶏のカンピロバクター感染を制御するための飲料
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
DK2861242T3 (en) 2012-06-18 2018-10-29 Heinz Co Brands H J Llc GLUTEN RELATED DISORDERS
US9458230B2 (en) * 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
PL2994150T3 (pl) 2013-05-10 2019-09-30 H.J. Heinz Company Brands Llc Probiotyki i sposoby zastosowania
US9468674B2 (en) 2013-09-24 2016-10-18 Wisconsin Alumni Research Foundation Methods of use of secretory IgA
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
WO2018220416A1 (en) * 2017-05-31 2018-12-06 Compagnie Gervais Danone Lactobacillus paracasei strain capable of improving the immune response to a viral-bacterial coinfection
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
JP2022529054A (ja) * 2019-04-17 2022-06-16 ニューテック・ベンチャーズ 持続性が強化された新規微生物を含む組成物、新規微生物とプレバイオティクスの相乗的組み合わせ、およびそのような微生物の分離方法
WO2020260502A1 (en) * 2019-06-28 2020-12-30 Societe Des Produits Nestle S.A. COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS
US20220248738A1 (en) * 2019-07-26 2022-08-11 Evolve Biosystems, Inc. NUTRITIVE COMPOSITIONS WITH SECRETED IgA, MILK FAT GLOBULE MEMBRANE COMPONENTS AND/OR BIFIDOBACTERIUM
EP4034145A4 (en) * 2019-09-24 2023-10-11 The Regents of the University of California BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN A
WO2021219786A1 (en) 2020-04-30 2021-11-04 Gottfried Himmler Anti-toxin secretory iga2 preparation
TWI823060B (zh) * 2021-02-26 2023-11-21 豐華生物科技股份有限公司 提升口腔免疫球蛋白a含量及抑制口腔病原菌之組成物及其用途
AU2022420738A1 (en) 2021-12-20 2024-05-30 Société des Produits Nestlé S.A. Secretory iga-biotic complexes and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5589233A (en) * 1978-12-28 1980-07-05 Shogo Nakano Preparation of additive for breeding of new born cattle
JP2968374B2 (ja) 1991-05-16 1999-10-25 株式会社ヤクルト本社 ＩｇＡ産生促進剤
JPH06234647A (ja) 1993-02-12 1994-08-23 Yakult Honsha Co Ltd ＩｇＡ産生促進剤およびその製造法
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
CA2291487A1 (en) * 1997-05-29 1998-12-03 New Zealand Pastoral Agriculture Research Institute Limited Processes for production of immunoglobulin a in milk
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
WO2003041512A1 (en) * 2001-11-12 2003-05-22 Mars, Incorporated Foodstuff
KR101095712B1 (ko) * 2003-08-21 2011-12-20 오츠카 세이야쿠 가부시키가이샤 점막 면역 부활 작용을 갖는 유산균
CA2596680C (en) * 2005-02-02 2013-06-18 Meiji Dairies Corporation Composition for immunostimulation
JP2008540462A (ja) * 2005-05-10 2008-11-20 マレー ゴールバーン コーオペラティブ コー リミテッド 免疫グロブリン分画およびそのためのプロセス
BRPI0615547A2 (pt) * 2005-08-19 2011-05-24 Unilever Nv produto alimentìcio, preparação farmacêutica, método de fabricação de produto alimentìcio, método de fabricação de preparação farmacêutica, uso do produto alimentìcio, usos da preparação farmacêutica, método de fornecimento de benefìcios à saúde do intestino e implementos de liberação para uso com produto alimentìcio
US20080145420A1 (en) * 2006-12-13 2008-06-19 Simon Michael R HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
JP5589233B2 (ja) 2011-08-24 2014-09-17 株式会社 ｌｉｆｅ ｐａｒｋ． ｂｉｚ 消火器の基台

Also Published As

Publication number Publication date
EP2318047B2 (en) 2018-08-15
WO2009156307A1 (en) 2009-12-30
EP2700411A1 (en) 2014-02-26
CA2727303A1 (en) 2009-12-30
US20120014963A1 (en) 2012-01-19
CN102076361A (zh) 2011-05-25
AU2009264423B2 (en) 2014-01-16
BRPI0914624B1 (pt) 2021-11-09
US20160106834A1 (en) 2016-04-21
EP2318047B1 (en) 2014-05-14
AU2009264423A1 (en) 2009-12-30
JP2011525484A (ja) 2011-09-22
PT2318047E (pt) 2014-06-24
ES2477882T5 (es) 2018-11-07
US20170281757A1 (en) 2017-10-05
US9173937B2 (en) 2015-11-03
BRPI0914624A2 (pt) 2015-10-20
PL2318047T3 (pl) 2014-10-31
PT2700411T (pt) 2017-03-29
US9629908B2 (en) 2017-04-25
EP2700411B1 (en) 2016-12-28
CN105816875A (zh) 2016-08-03
EP2138187A1 (en) 2009-12-30
EP2318047A1 (en) 2011-05-11
ES2477882T3 (es) 2014-07-18
ES2616334T3 (es) 2017-06-12

Similar Documents

Publication Publication Date Title
PT2700411T (pt) Probióticos, iga secretora e infecção
PL2318046T3 (pl) Probiotyki, wydzielnicze IGA i zapalenie
HK1158558A1 (en) Limited-access, reduced-pressure systems and methods
PL3729998T3 (pl) Złożony element zawierający dwa elementy panelowe
BRPI1010574A2 (pt) cereal infantil compreendendo micro-organismos probióticos não replicantes.
EP2518147A4 (en) DIACYLGLYCEROLACYLTRANSFERASEGEN AND ITS USE
IL210804A (en) Benzylidenehydrazides and their uses
PL2354161T3 (pl) Przeciwciało anty -NR10 i jego zastosowanie
HK1156326A1 (en) Anti-hepcidin-25 selective antibodies and uses thereof
AP2011006039A0 (en) Mobile self-contained stone-making and concrete-processing factory.
ZA201001029B (en) Vaccines
EP2416300A4 (en) WIRELESS DISASTER KNOCKING NODES AND WIRELESS DISABLED DISABLING SYSTEM
EP2402429A4 (en) EQUOL-PRODUCING BACTERIUM AND ITS USE
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
EP2399661A4 (en) METHOD FOR MANUFACTURING GAS ADSORPTION DEVICE, GAS ADSORPTION DEVICE, AND METHOD OF USING SAME
SI2354161T1 (sl) Anti-NR10 protitelo in njegova uporaba
EP2247601A4 (en) THIAZOPYRIMIDINONE AND APPLICATIONS THEREOF
EP2491946A4 (en) ADJUVANT FOR VACCINES, VACCINES COMPRISING SAME, AND USES THEREOF
EP2515903A4 (en) COMPOUNDS, PREPARATION AND USES THEREOF
AP2012006303A0 (en) Anti-trypanosomiasis vaccines and diagnostics.
GB0703763D0 (en) Bone-replacement materials,methods and devices
EP2123376A4 (en) STOP STRUCTURE AND MANUFACTURING METHOD THEREFOR
TWI346557B (en) Adjuvant and vaccine includes the same
HK1143499A2 (en) Anti-lose system and wireless node devices used for the system
EP2322806A4 (en) NOZZLE PRESSURE BLOWER